Early detection of Alzheimer's disease through neuroimaging
Develop a non-invasive neuroimaging technology to detect early signs of Alzheimer's disease. This could significantly improve diagnosis and treatment outcomes. Market size: According to a report by Grand View Research, the global Alzheimer's disease diagnostics market is expected to reach $10 billion by 2026.
Neuroimaging
United States
